サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433399

ヘルスケアにおけるeConsentの世界市場：2023-2030年

Global EConsent in Healthcare Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 160 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ヘルスケアにおけるeConsentの世界市場：2023-2030年
出版日: 2023年12月20日
発行: Orion Market Research
ページ情報: 英文 160 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヘルスケアにおけるeConsentの世界市場は、予測期間（2023-2030年）にCAGR 9.9％で成長すると予測されます。同市場の成長の背景には、スポンサーの管理能力の向上があります。eConsentソリューションに段階的なライセンスオプションと追加機能が追加されたことで、スポンサーはより多くのコントロールとカスタマイズ機能を利用できるようになった。これは、研究のニーズに基づいてカスタマイズされた同意ソリューションへの欲求を満たすものです。例えば、2021年4月、シグナントヘルス社は、最新のSmart Signals eConsentをリリースし、電子インフォームド・コンセント製品を拡大し、その機能を強化しました。 主な製品の機能強化と段階的なライセンスオプションにより、スポンサーは研究デザインに対する電子的なインフォームド コンセントと再同意の取得をさらにコントロールすることができます。

セグメント別の展望

オンサイトサブセグメントがヘルスケアにおけるeConsentの世界市場で大きなシェアを占めると予想されます。

アプリケーションの中では、コンテンツ管理システム（CMS）サブセグメントが世界のヘルスケアにおけるeConsent市場でかなりのシェアを占めると予想されます。このセグメントの成長は、多様な人々のエンゲージメントに起因しています。現場でのeConsentは、さまざまな程度のデジタルリテラシーを持つ人やテクノロジーへのアクセスが制限されている人など、さまざまな層に対応でき、裁判資料への公平なアクセスを可能にします。例えば、2021年7月、CASTORはスケーラブルな患者登録およびeConsentプラットフォームを発表しました。臨床試験が分散化されることで、より多くの人々が臨床試験にアクセスできるようになります。さらに、このプロセスは透明性と効率性を促進し、試験の募集・登録プロセス全体を通じてシームレスな移行を提供することで患者の負担を軽減します。

地域別展望

ヘルスケアにおけるeConsentの世界市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、その他アジア太平洋地域（中東とアフリカ、その他南米）を含む地域別にさらに細分化されています。なかでも欧州は、医療制度が発達していることに加え、データ保護と患者の権利を重視しているため、eConsentソリューションが魅力的な選択肢となっており、世界市場で大きなシェアを占めると予想されます。電子カルテの普及や相互運用性の標準化など、ヘルスケアのデジタル化への取り組みが増加していることも、eConsentの展開に好都合な環境をもたらしています。

北米地域は、ヘルスケアにおけるeConsentの世界市場において著しいCAGRで成長する見込みです。

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の成長は、比較理解研究に起因しています。紙ベースのインフォームド・コンセント・フォーム（ICF）とは対照的に、eConsentに関する患者の理解度を比較する比較調査では、肯定的な結果が得られています。これらの研究は、eConsentingに関する知識の向上または同等であることを強調し、eConsentingの受け入れに貢献しています。2023年9月のNational Institute of Health（gov.）によると、適格基準を満たした合計36の研究がこのレビューに含まれ、さらに手作業で検索されたアウトカムの出版物が追加されました。これらの出版物には合計35件の研究が記載されており、2件の研究がそれぞれ2件の出版物でカバーされていました。研究の大部分（28/35、80％）は北米で実施され、米国が26研究、カナダが2研究でした。

さらに、合計8,778人が参加した26の研究の包括的な分析において、eConsentingに関連して患者の理解の側面が評価されました。これらの研究のうち、20の研究ではeConsentingと紙ベースのインフォームド・コンセント・フォーム（ICF）の理解度を特に比較し、合計6,769人の参加者が比較データを提供しています。その結果、紙ベースのICFと比較した場合、eConsentingの方が有意に理解度が高い、統計的有意差はないが理解度が高い、または理解度全体において有意差がないことが示されました。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • Citadel Group Ltd.
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Florence Healthcare, Inc.
    • 会社概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • Health Catalyst
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • ヘルスケアにおけるeConsentの世界市場：登録タイプ別
    • オンサイト
    • 遠隔同意
  • ヘルスケアにおけるeConsentの世界市場：展開モード別
    • クラウドベース
    • ウェブベース
  • ヘルスケアにおけるeConsentの世界市場：フォームタイプ別
    • 一般的同意
    • 特定の拒否を伴う一般的同意
    • 特定の同意を伴う一般的拒否
    • 一般的拒否

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • 5thPort, LLC
  • Calysta EMR
  • Cloudbyz
  • Concentric
  • EvidentIQ Group GmbH
  • IQVIA
  • Magentus Group Pty Ltd.
  • Medable, Inc.
  • Medrio, Inc.
  • ObvioHealth
  • Signant Health
  • Sitero
  • Suvoda LLC,
  • Thieme Compliance GmbH
  • Veeva Systems
図表

LIST OF TABLES

  • 1. GLOBAL ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL ON-SITE ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL REMOTE ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 5. GLOBAL ECONSENT IN HEALTHCARE CLOUD-BASED MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL ECONSENT IN HEALTHCARE WEB-BASED MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)
  • 8. GLOBAL GENERAL CONSENT ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL GENERAL CONSENT WITH SPECIFIC DENIAL(S) ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL GENERAL DENIAL WITH SPECIFIC CONSENT(S) ECONSENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL GENERAL DENIAL ECONSENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)
  • 17. EUROPEAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. EUROPEAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 19. EUROPEAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 20. EUROPEAN ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY ENROLLMENT TYPE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY DEPLOYMENT MODE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET RESEARCH AND ANALYSIS BY FORM TYPE, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL ECONSENT IN HEALTHCARE MARKET SHARE BY ENROLLMENT TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL ON-SITE ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL REMOTE CONSENT ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL ECONSENT IN HEALTHCARE MARKET SHARE BY DEPLOYMENT MODE, 2022 VS 2030 (%)
  • 5. GLOBAL ECONSENT IN HEALTHCARE CLOUD-BASED MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL ECONSENT IN HEALTHCARE WEB-BASED MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL ECONSENT IN HEALTHCARE MARKET SHARE BY FORM TYPE, 2022 VS 2030 (%)
  • 8. GLOBAL GENERAL CONSENT ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL GENERAL CONSENT WITH SPECIFIC DENIAL(S) ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. GLOBAL GENERAL DENIAL WITH SPECIFIC CONSENT(S) ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL GENERAL DENIAL ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL ECONSENT IN HEALTHCARE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. US ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. CANADA ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. UK ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. FRANCE ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. GERMANY ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ITALY ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SPAIN ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. REST OF EUROPE ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. INDIA ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CHINA ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. JAPAN ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SOUTH KOREA ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF ASIA-PACIFIC ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD ECONSENT IN HEALTHCARE MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027988

Global EConsent in Healthcare Market Size, Share & Trends Analysis Report by Enrollment Type (On-site, and Remote Consent), by Deployment Mode (Cloud-based, and Web-based) and by Form Type (General Consent, General Consent with Specific Denial(s), General Denial with Specific Consent(s), and General Denial), Forecast Period (2023-2030)

The global econsent in healthcare market is anticipated to grow at a CAGR of 9.9% during the forecast period (2023-2030). The market's growth is attributed to the increased sponsor control. The addition of tiered license options and extra features in eConsent solutions offers sponsors more control and customization capabilities. This satisfies the desire for customized consent solutions based on the needs of the study. For instance, in April 2021, Signant Health, with the latest released of Smart Signals eConsent, the company has expanded its electronic informed consent products and strengthened its capabilities. Key product functionality enhancements and tiered license options offer sponsors additional control over getting electronic informed consent and reconsent for any study design.

Segmental Outlook

The global econsent in healthcare market is segmented on the enrollment type, deployment mode, and form type. Based on the enrollment type, the market is sub-segmented on-site, and remote consent. Based on the deployment mode, the market is sub-segmented into cloud-based, and web-based. Furthermore, on the basis of form type, the market is sub-segmented into general consent, general consent with specific denial(s), general denial with specific consent(s), general denial. The cloud-based subcategory is expected to capture a significant portion of the market share within the deployment mode segment. The growth can be attributed to the growing use of cloud-based solutions owing to the benefits of minimizing administrative burden and maintaining compliance for sites and study teams. Furthermore, cloud-based eConsent improves the process by incorporating innovative technology and multimedia to provide potential trial participants with an interactive informed consent experience.

The On-Site Sub-Segment is Anticipated to Hold a Considerable Share of the global EConsent in Healthcare Market

Among the application, the content management systems (CMS) sub-segment is expected to hold a considerable share of the global econsent in healthcare market. The segmental growth is attributed to the diverse populations engagement. On-site eConsent can serve a variety of demographics, including those with various degrees of digital literacy or restricted access to technology, enabling fair access to trial material. For instance, in July 2021,CASTOR Launched Scalable Patient Enrollment and eConsent Platform. Clinical trials benefit from decentralization as it makes them more accessible to a wider range of individual. The process additionally encourages transparency and efficiency, reducing the burden on patients by providing a seamless transition throughout the study recruitment and enrollment process.

Regional Outlook

The global econsent in healthcare market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to the region's healthcare system is well-developed, in addition to is a significant emphasis on data protection and patient rights, making eConsent solutions an appealing option. The increasing healthcare digitization initiatives, such as widespread adoption of electronic health records and interoperability standards, present a conducive climate for eConsent deployment.

The North America Region is Expected to Grow at a Significant CAGR in the global EConsent in Healthcare Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the comparative comprehension studies. Comparative research comparing patient comprehension of eConsenting opposed to paper-based Informed Consent Forms (ICFs) has produced positive results. These studies emphasizing improved or comparable knowledge of eConsenting assist to its acceptance. According to the National Institute of Health (gov.) in September 2023, a total of 36 studies meeting the eligibility criteria were included in this review, along with an additional outcomes publication that was retrieved manually. These publications described a total of 35 studies, with 2 studies covered by 2 publications each. The majority of the studies (28/35, 80%) were conducted in North America, with the US accounting for 26 studies and Canada for 2 studies.

Furthermore, in a comprehensive analysis of 26 studies involving a total of 8,778 participants, the aspects of patient comprehension were evaluated in relation to eConsenting. Out of these studies, 20 specifically compared comprehension between eConsenting and paper-based informed consent forms (ICFs), with a total of 6,769 participants contributing comparative data. The findings indicated that eConsenting demonstrated either significantly better understanding, better understanding without statistical significance, or no significant differences in overall comprehension when compared to paper-based ICFs.

Market Players Outlook

The major companies serving the econsent in healthcare market includes Magentus Group Pty Ltd., Medable, Inc., Medrio, Inc., ObvioHealth, and Veeva Systems and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance In June 2022, uMotif partnered with ClinOne to provide a seamless experience for patients, caregivers, and sites of proven traditional, DCT, and hybrid trial solutions for eConsent, eCOA / ePRO, behavioral engagement, sensors and wearables, and more.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global econsent in healthcare market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Citadel Group Ltd.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Florence Healthcare, Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Health Catalyst
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global EConsent in Healthcare Market by Entrollment Type
    • 4.1.1. On-site
    • 4.1.2. Remote Consent
  • 4.2. Global EConsent in Healthcare Market by Deployment Mode
    • 4.2.1. Cloud-Based
    • 4.2.2. Web-Based
  • 4.3. Global EConsent in Healthcare Market by Form Type
    • 4.3.1. General Consent
    • 4.3.2. General Consent With Specific Denial(S)
    • 4.3.3. General Denial With Specific Consent(S)
    • 4.3.4. General Denial

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 5thPort, LLC
  • 6.2. Calysta EMR
  • 6.3. Cloudbyz
  • 6.4. Concentric
  • 6.5. EvidentIQ Group GmbH
  • 6.6. IQVIA
  • 6.7. Magentus Group Pty Ltd.
  • 6.8. Medable, Inc.
  • 6.9. Medrio, Inc.
  • 6.10. ObvioHealth
  • 6.11. Signant Health
  • 6.12. Sitero
  • 6.13. Suvoda LLC,
  • 6.14. Thieme Compliance GmbH
  • 6.15. Veeva Systems